Home©¦Faculty©¦General Information©¦Live Case Sites©¦Case review©¦Abstract review©¦Exhibition©¦Beijing Tour©¦CIT2006©¦Contact Us©¦ÖĐÎÄ
 

Program




 
 
   
   
 
Luncheon Satellite Symposium ( Luncheon workshop Evening Satellite Symposium )
   
  March 30, 2007£¬Hall 1
  Drug-Eluting Stent: State of the Art
  Sponsored by MicroPort
  Moderators Junbo Ge
Shuzheng Lu
Jiyan Chen
Liliana R. Grinfeld
Yaron Almagor
   
 

12:15 PM - Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus-Eluting Stent: Firebird In China (FIC) Registry
Runlin Gao
Interpreter Jie Qian

12:30 PM - A Prospective, Multicenter, FIM Study of Second Generation Sirolimus Eluting Cobalt Alloyed IREBIRD 2 Stent: 6-Month Angiographic and IVUS Results, and 1-Year Clinical utcomes
Weifeng Shen
Interpreter Qi Zhang

12:45 PM - An Overview of the Latest Approach to Bifurcation Lesion
Yaron Almagor
Interpreter Jian Liu

1:00 PM - Moderated Q&A Roundtable Discussion

1:12 PM - Conclusion

1:15 PM - Adjourn

   
   
  March 31, 2007£¬Hall 17
  Sponsored by JW Medical
  Moderators Runlin Gao
Yuejin Yang
Shuzheng Lu
   
 

12:15 PM - Introduction

12:20 PM - Twelve-Month Clinical, Angiographic and IVUS Follow-up Results From EXCEL CREATE Pilot Study
Yaling Han

12:35 PM - Current Status and Development of Drug-Eluting Stent
Eberhard Grube

12:50 PM - Two-Year Follow-up Results of EXCEL First-in-Man Clinical Study
Teguh Santoso

1:05 PM - Moderated Q&A Roundtable Discussion

1:15 PM - Adjourn

   
   
 
Luncheon workshop  
   
  March 29, 2007£¬Hall 2
  Focus 2007 Global Hotspots: New Antithrombotic Strategies in PCI
  Sponsored by Sanofi-Aventis
  Moderators Runlin Gao
Yong Huo
   
  12:00 PM - From Guideline to Practice: The Clinical Management of PCI
Runlin Gao

12:25 PM - Prevention of Late Stent Thrombosis Post-PCI
Yong Huo

12:50 PM - New Insight into Anticoagulation in PCI
Yundai Chen

1:15 PM - Panel Discussion and Q&A

1:20PM - Conclusion

1:30 PM - Adjourn

   
   
  March 30, 2007£¬Hall 2
  Comprehensive Prevention Strategy of Cardiovascular Disease
  Sponsored by Bayer
  Moderators Runlin Gao
Yaling Han
   
  12:15 PM - Postprandial Hyperglycemia in Cardiovascular Complication
Dajin Zou

12:40 PM - The Clinical Strategy on Platelet Aggregation Inhibitor
Shuyang Zhang

1:05 PM - Moderated Q&A Roundtable Discussion

1:15 PM - Conclusion

1:20 PM - Adjourn

   
   
  March 30, 2007£¬Hall 6
 

Sponsored by Lepu Medical

  Moderators Zhanquan Li
Jianhua Zhu
Ben He
Qiangsun Zheng
   
  12:15 PM - Long-term Safety and Clinical Strategy on Drug Eluting Stent
Shubin Qiao

12:35 PM - The State-of-the-art in New DES Research
Yong Huo

12:55 PM - Latest Research and Development of LEPU Nano Polymer-free DES
Ming Yang

1:15 PM - Conclusion

1:20 PM - Adjourn

   
   
  March 30, 2007£¬Hall £·
  Sponsored by JW Medical
  Moderators Jilin Chen
Weimin Wang
   
 

12:15 PM - Introduction

12:20 PM - The Advantage of Biodegradable Polymer-Based Drug-Eluting Stent
Juying Qian

12:35 PM - Common Problems and Treatment Strategies in Emergent PCI for STEMI
Hongbing Yan

12:50 PM - Treatment of Bifurcation Lesion in TRI
Xueqi Li

1:05 PM - Panel Discussion and Q&A

1:15 PM - Adjourn

   
   
  March 30, 2007£¬Hall 8
 

CTO Approach: Get Beyond the Limitation
Sponsored by Terumo

  Moderators Yuejin Yang
Ben He
Zhimin Du
 
12:15 PM - CART (Controlled Antegrade and Retrograde Subintimal Tracking) Wire Technique

Shigeru Saito

12:35 PM - Treatment of Complex CTO Lesions
Yuejin Yang

12:55 PM - The Key Tips of CTO Treatment
Weimin Li

1:15 PM - Conclusion

1:20 PM - Adjourn

   
   
  March 30, 2007£¬Hall 17A
  Key Issues Had to Be Concerned in the Era of DES
  Sponsored by Abbott Vascular
  Moderators Shubin Qiao
Haichang Wang
   
  12:15 PM - The Importance of Pre- and Post- Dilatation in the Era of DES
Yundai Chen

12:30 PM - Will DES Totally Replace BMS in All Patient/Lesion Subsets? - The Indication of BMS Usage in the Era of DES
Weimin Wang

12:45 PM - Case Presentation 1
Lijun Guo

12:55 PM - Case Presentation 2
Xuebo Liu

1:05 PM - Panel Discussion and Q&A

1:15 PM - Adjourn

   
   
  March 30, 2007£¬Hall 17B
  The Update of AFIB Catheter Ablation and China Experience
  Sponsored by Cordis, A Johnson & Johnson Company
  Moderator Shu Zhang
   
  12:15 PM - Update in Boston AFIB Symposium 1
Changsheng Ma

12:30 PM - Update in Boston AFIB Symposium 2
Jian Ma

12:45 PM - Success and Issues in Clinical Application of AFIB Ablation in China
Congxin Huang

1:05 PM - Moderated Q&A Roundtable
Discussion

1:10 PM - Conclusion

1:15 PM - Adjourn

   
   
  March 31, 2007£¬Hall 2
  A Story of the First China-Made Drug-Eluting Stent: Growing Evidence of FIREBIRD
  Sponsored by MicroPort
  Moderators Weimin Wang
Shubin Qiao
Weiyi Fang
   
 

12:15 PM - Angiographic Follow-up Results of FIREBIRD DES From a Large Single Center Database: omparison with Other Workhorse DESs in All Complex Lesion Subsets
Bo Xu

12:30 PM - Final Angiographic and Long-term Clinical Results From a Single Center, Randomized Study of IREBIRD DES Versus BMS in AMI: Update on FIBISTEMI Trial
Hongbing Yan

12:45 PM - A Prospective, Multicenter Study of FIREBIRD Sirolimus-Eluting Stent in the Treatment of Complex Coronary Artery Disease: Update on FIREMAN Registry
Haichang Wang

1:00 PM - Moderated Q&A Roundtable Discussion

1:12 PM - Conclusion

1:15 PM - Adjourn

   
   
  March 31, 2007£¬Hall 6
  Experience Innovation from SIEMENS
Sponsored by SIEMENS
  Moderators Kejiang Cao
Jiyan Chen
   
  12:15 PM - Current Status and Prospect: The Applications of Angiographic CT in Intervention
K. Klingenbeck

12:35 PM - The Advanced Applications of Cutting-edge Dual Source CT in Cardiac Intervention
Zhengyu Jin

12:55 PM - Advanced MR Application in Coronary Heart Disease
Shihua Zhao

1:15 PM - Panel Discussion and Q&A

1:20 PM - Adjourn

   
   
  March 31, 2007£¬Hall 7
  Right Time, Right Devices!
  Sponsored by Medtronic
  Moderators Jilin Chen
Jiyan Chen
   
 

12:15 PM - Introduction

12:20 PM - Guiding Selection for Complex Lesion during PCI
Yujie Zhou

12:35 PM - New Choice of Workhorse Wire in Daily Practice
Lefeng Wang

12:50 PM - The Necessity of GuardWire EPD System during SVG and AMI Intervention
Hongbing Yan

1:05 PM - Moderated Q&A Roundtable Discussion

1:12 PM - Conclusion

1:15 PM - Adjourn

   
   
  March 31, 2007, Hall 8
  Cardiac Intervention in Complex Lesions
  Sponsored by St. Jude Medical (Shanghai) Ltd.
  Moderators Jiyan Chen
Weimin Wang
Juying Qian
   
 

12:15 PM - Venture Wire Control Catheter Application in Challenging cases
Jianfang Luo

12:40 PM - An innovative tool for treating Challenging Cases
Jian Liu

1:05 PM - Panel Discussion and Q&A

1:10 PM - Conclusion

1:15 PM - Adjourn

   
   
  March 31, 2007£¬Hall 17A
 

Sponsored by Pfizer

  Moderators Weifeng Shen
Yong Huo
   
  12:15 PM - Strategies of Lipid-Lowering Therapy for High Risk Patients
Ben He

12:45 PM - Optimal Anticoagulation Therapy for ACS Patients with Mild to Moderate Renal Failure
Yundai Chen

1:15 PM - Panel Discussion and Q&A

1:20 PM - Adjourn

   
   
  March 31, 2007£¬Hall 17B
  Challenging Case Review from OLYMPIA in China
  Sponsored by Boston Scientific
  Moderators Meng Wei
Yawei Xu
   
 

12:10 PM - Case Presentation 1
Hongliang Cong

12:15 PM - Case Presentation 2
Lei Ge

12:20 PM - Discussion

12:28 PM - Case Presentation 3
Wenyi Guo

12:33 PM - Case Presentation 4
Ben He

12:38 PM - Discussion

12:46 PM - Case Presentation 5
Tianchang Li

12:51 PM - Case Presentation 6
Shouli Wang

12:56 PM - Discussion

1:04 PM - Case Presentation 7
Qinzhu Wen

1:09 PM - Case Presentation 8
Shangyu Wen

1:14 PM - Discussion

1:22 PM - Conclusion

1:25 PM - Adjourn

   
   
  April 1,2007,Hall 7
  Pay Close Attention to Clinical Data on Interventional Cardiology
  Jointly Sponsored by CCHEART Review and MSD HCN
  Moderator Bo Xu
  Discussants Yundai Chen
Lei Ge
Lang Li
Jian Liu
   
  12:15 PM - From Evidence-based Medicine to Clinical Practice: Pay Close Attention to Clinical Data on Interventional Cardiology!
Jian Liu

Flash Debate 1 - To Think or to Act

12:30 PM - Action First, then Update Mind!
Jianxiong Liu

12:35 PM - Update Mind First, and then Action!
Shaoping Chen

12:40 PM - Panel Discussion and Audience Response

Flash Debate 2 - How to Collect and Save Effective Clinical Data

12:50 PM - Clinical Follow-up Is NOT Equal to Daily Out-patient Clinic
Jie Song

12:55 PM - Daily Out-patient Clinic Is Approximately Equal to Clinical Follow-up
Xiantao Song

1:00 PM - Panel Discussion and Audience Response

1:10 PM - The Value of Clinical Data on Interventional Cardiology and Challenge in Reality
Lei Ge

1:22 PM - Conclusion

1:25 PM - Adjourn

   
   
  April 1,2007,Hall 8
  How to Prevent the In-hospital Cardiac and Renal Complications in High-risk PCI Patients?
 

Sponsored by GE Healthcare

  Moderators Guoying Zhu
Weifeng Shen
 
12:15 PM - The Latest PCI Strategy in Patient with Renal Dysfunction

Weifeng Shen

12:35 PM - Contrast-induced Nephropathy (CIN): The Fateful Weakness in PCI
Jiyan Chen

12:55 PM - Contrast Media and Thrombosis: The More We Know, the More We Need to Know
Yujie Zhou

1:15 PM - Panel Discussion and Q&A

1:20 PM - Adjourn

   
   
  Evening Satellite Symposium
   
  March 30, 2007£¬Hall 2
  Safety First!
  Sponsored by Medtronic
  Moderators Runlin Gao
Yong Huo
Shuzheng Lu
Bo Xu
   
 

6:00 PM - Introduction

6:10 PM - Endeavor Clinical Program Update
Martin B. Leon
Interpreter Liu, Jian

6:35 PM - Making Practical Clinical Sense of All the Data in this DES Era
Spencer B. King III
Interpreter Liu, Jian

7:00 PM - Real World Experience of DES in China
Junbo Ge

7:20 PM - Moderated Q&A Roundtable Discussion

7:25 PM - Conclusion

7:30 PM - Adjourn

   
   
  March 30, 2007£¬Hall 17
  TAXUS ¨C What We Can Learn From You for the Next Generation DES?
  Sponsored by Boston Scientific
  Moderators Jiyan Chen
Yuejin Yang
Guoying Zhu
  Interpreter Yi Li
   
  6:00 PM - Introduction

6:05 PM - Delivering What We Have Learned So Far
Gregg W. Stone

6:30 PM - TAXUS in Treating Unprotected Left Main Coronary Artery Disease
Yaling Han

6:55 PM - IVUS Findings Across TAXUS Clinical Programs
Gary S. Mintz

7:20 PM - Moderated Q&A Roundtable Discussion

7:27 PM - Conclusion

7:30 PM - Adjourn

   
   
  March 31, 2007£¬Hall 2
  Treatment of Complex Lesions and the Safety of CYPHER from the Evidence-based Medicine Perspective
  Sponsored by Cordis, A Johnson & Johnson Company
  Moderators Jilin Chen
Zhimin Du
Yong Huo
   
  6:00 PM - Techniques and Evidence in Treating Complex Lesions
Antonio Colombo
Interpreter Yu Wang

6:40 PM - Evaluation on the Safety Profile of CYPHER DES
Yean-Leng Lim

7:00 PM - Paradoxes and Perplexities in PCI
Shuzheng Lu

7:20 PM - Moderated Q&A and Discussion

7:30 PM - Adjourn

   
   
  March 31, 2007£¬Hall 17
  Xience V Everolimus-Eluting Stent: Beyond Targeting Restenosis!
  Sponsored by Abbott Vascular
  Moderator Runlin Gao
  Co-oderators Jiyan Chen
Junbo Ge
Yuejin Yang
  Interpreter Jian Liu
   
  6:00 PM - Introduction

6:05 PM - The Science Behind Xience V¡ª¡ª SPIRIT III: 9-Month Results of the US Pivotal Trial
Gregg W. Stone

6:30 PM - Comparison of First and Second Generation DES¡ª¡ªFrom Preclinical to Clinical
Mitchell W. Krucoff

6:50 PM - ABSORB: 6-Month Results of First-in-Man Registry Study With the Bioabsorbable Everolimus-Eluting Stent
Patrick W. Serruys

7:10 PM - Panel Discussion and Q&A

7:25 PM - Conclusion

7:30 PM - Adjourn

   
   
   
   
2000-2007 CCheart Consulting Co.Ltd.All Rights Reserved
EMAIL:adm@ccheart.com.cn